Biliary Dyskinesia Clinical Trials in Saint Petersburg
2 recruitingSaint Petersburg, Russia
Showing 1–2 of 2 trials
Recruiting
Phase 1
Pharmacokinetics, Bioequivalence, and Safety Study of Trimedat® 76,95 mg Orally Disintegrating Tablets and Trimedat® 100 mg Tablets in Healthy Volunteers.
Gallstone DiseaseIrritable Bowel SyndromeGERD+2 more
Valenta Pharm JSC36 enrolled1 locationNCT07421011
Recruiting
Phase 2
Efficacy, Safety, and Tolerability of 4-MUST Tablets in Chronic Cholecystitis and Biliary Dyskinesia
Biliary DyskinesiaChronic Cholecystitis
Valenta Pharm JSC300 enrolled17 locationsNCT06842966